Vacina Nasal para Neisseria meningitidis B: Importância das Pesquisas Utilizando Novas Metodologias para o Preparo de Vacinas
PDF (Português (Brasil))

Cómo citar

1.
De Gaspari EN. Vacina Nasal para Neisseria meningitidis B: Importância das Pesquisas Utilizando Novas Metodologias para o Preparo de Vacinas. Bepa [Internet]. 31 de mayo de 2004 [citado 25 de noviembre de 2024];1(5):9-13. Disponible en: https://periodicos.saude.sp.gov.br/BEPA182/article/view/38994

Resumen

 

 

PDF (Português (Brasil))

Citas

1.Goldchneider I, Gotschlich EC, Artenstein MS. Human immunity to the Meningococcus. II. Development of natural immunity J Exp Med 1969; 129:1327.

2.Haneberg B, Dalseg R, Wedege E, Hoiby EA, Haugen IL, Oftung F, Andersen SR, Naess LM, Aase A, Michaelsen TE, Holst J. Intranasal administration of a meningococcal outer membrane vesicle vaccine induces persistent local mucosal antibodies and serum antibodies with strong bactericidal activity in humans. Infect Immun. 1998; 66:1334.

3.Oftung F, Naess LM, Wetzler LM, Korsvold GE, Aase A, Hoiby EA, Dalseg R, Holst J, Michaelsen TE, Haneberg B. Antigen-specific T-cell responses in humans after intranasal immunization witha meningococcal serogroup B outer membrane vesicle vaccine. Infect Immun. 1999 67:921.

4.Saunders NB, Shoemaker DR, Brandt BL, Moran EE, Larsen T, Zollinger WD. Immunogenicity of intranasally administered meningococcal native outer membrane vesicles in mice. Infect Immun. 1999; 67:113.

5.Drabick JJ, Brandt BL, Moran EE, Saunders NB, Shoemaker DR, Zollinger WD. Safety and immunogenicity testing of an intranasal group B meningococcal native outer membrane vesicle vaccine in healthy volunteers. Vaccine. 1999; 18:160.

6.Katial RK, Brandt BL, Moran EE, Marks S, Agnello V, Zollinger WD. Immunogenicity and safety testing of a group B intranasal meningococcal native outer membrane vesicle vaccine.Infect Immun. 2002; 70:702.

7.Guthrie T, Wong SY, Liang B, Hyland L, Hou S, Hoiby EA, Andersen SR. Local and systemic antibody responses in mice immunized intranasally with native and detergent-extracted outer membrane vesicles from Neisseria meningitidis. Infect Immun. 2004; 72:2528.

8.De Gaspari EN. Em busca de uma vacina nasal contra a meningite. Revista de Pesquisa FAPESP 1998: 36:10.

9.De Gaspari EN. Vacina nasal contra meningite. Ciência Hoje 1998:151.

De Gaspari EN, Ribeiro, AA, Baccocini, CN, Zollinger, WD. The use of filter paper monoclonal antibodies in a Dot-blot test for typing Neisseria meningitidis B. Braz. J. Med. Biol. Res. 1994;27: 2889.

11.De Gaspari EN. A new monoclonal antibody against outer membrane complex (50KD) of Neisseria meningitidis modify the course of bacteremia in a mouse model. An. Acad. Bras. Cienc 1995; 96:63.

12.De Gaspari EN. Production and characterization of a new monoclonal antibody against Neisseria meningitidis: study of the cross-reactivity with different bacterial genera. Hybridoma 2000; 19:445.

13.De Gaspari EN. Uma visão retrospectiva das principais vacinas para Neisseria meningitidis B. LAES HAES 2000; 122:130.

14.De Gaspari EN, Zollinger W. Expression of class 5 antigens by meningococcal strains obtained from patients in Brazil and evaluation of two new monoclonal antibodies. Braz. J. Infect. Dis. 2001; 5:143.

15.Belo EFT, De Gaspari EN. Produção e caracterização de dois novos anticorpos monoclonais para imunotipos de LPS importantes na seleção de cepas para o preparo de vacinas de Neisseria meningitidis B. Rev. Inst. Adolfo Lutz 2001;.60.

16.Coutinho LMCC. Uso de anticorpos monoclonais na seleção de antígenos lipopolissacáride da cepa epidêmica de B:4:P1.15 de Neisseria meningitidis: Imunização intranasal. São Paulo, 2002. (Dissertação de Mestrado, Faculdade de Ciências Farmacêuticas, Universidade de São Paulo).

17.Thomaz BeloEF. Expressão antigênica de LPS das cepas meningocócicas prevalentes no Brasil, produção de anticorpos monoclonais como subsídeos para estudos epidemiológicos ,2002. (Dissertação de Mestrado, Faculdade de Ciências Farmacêuticas, Universidade de São Paulo).

18.De Gaspari EN. Identification of a novel membrane protein of Neisseria meningitidis and its potential as a vaccine candidate. Immunol Lett 1999; 69.

19.Seneme Ferraz A, Coutinho LMC, Thomaz Belo EF, Oliveira APS, De Gaspari EN. Immunogenicity of a highly conserved Neisseria meningitidis surface protein in rabbit after nasal immunization with native outer membrane vesicles Eur. J. Pharm. Sci 2000; 13:91.

20.Tunes CF, Thomaz Belo EF, Coutinho LMCC, Ferraz AS, Carmo AMS, Ito AY, Néri SV, De Gaspari, EN. Intranasal priming with Neisseria lactamica for the induction of a systemic imune response against Neisseria meningitidis. Rev Inst Adolfo Lutz 2003; 62:50.

21.Néri SV, Carmo MAS, Tunes CF, Ferraz AS, Thomaz Belo EF, Coutinho LMCC, Ito AY, De Gaspari EN. Immune response of neonatal mice priming with heat inativated Neisseria lactamica. Rev Inst Adolfo Lutz 2003; 62:50.

22.Carmo MAS, Ito AY, Néri SV, Tunes CF, Thomaz Belo EF, Coutinho LMCC, Ferraz AS, De Gaspari EN. Imunização nasal: Estudo da resposta imune em camundongos neonatos imunizados com Neisseria meningitidis B e Bordetella pertussis como adjuvante Rev Inst Adolfo Lutz 2003; 62:38.

23.Ito AY, Néri SV, Carmo AMS, Thomaz Belo EF, Tunes CF, Coutinho LMCC, De Gaspari EN. Immune response in neonatal and infants mice immunized intranasally with native outer membrane vesicles of Neisseria meningitidis selected to L379 orL8 . Rev Inst Adolfo Lutz, 2003; 62:49.

24.Coutinho LMCC, Thomaz Belo EF, Seneme Ferraz A, Oliveira APS, De GaspariEN. Vacinas de mucosa: Imunização intranasal para Neisseria meningitidis B. LAES HAES 2004; 96-132.

Creative Commons License

Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.

Derechos de autor 2004 De Gaspari EN

Descargas

Los datos de descargas todavía no están disponibles.

Métricas

Cargando métricas ...